Growth Metrics

Gyre Therapeutics (GYRE) Cash & Equivalents Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -51.77%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 24.73%
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -28.55%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 13.33%
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -16.07%
7 Evaxion A 62.56 Bn 62.54 Bn - 21.66%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -8.88%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 36.53%
10 Gyre Therapeutics 532.38 Mn 518.25 Mn 8.38 Mn 43.66%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 43.66%
Dec 31, 2025 -0.40%
Sep 30, 2025 20.48%
Jun 30, 2025 -27.57%
Mar 31, 2025 -52.69%
Dec 31, 2024 -35.68%
Sep 30, 2024 -35.51%
Jun 30, 2024 -39.75%
Mar 31, 2024 -56.70%
Dec 31, 2023 -25.76%
Sep 30, 2023 -55.47%
Jun 30, 2023 -42.06%
Mar 31, 2023 -43.56%
Dec 31, 2022 -31.07%
Sep 30, 2022 -35.23%
Jun 30, 2022 63.19%
Mar 31, 2022 11.64%
Dec 31, 2021 -28.05%
Sep 30, 2021 18.01%
Jun 30, 2021 16.52%
Mar 31, 2021 -5.44%
Dec 31, 2020 29.58%
Sep 30, 2020 31.45%
Jun 30, 2020 22.32%
Mar 31, 2020 69.17%
Dec 31, 2019 95.65%
Sep 30, 2019 108.95%
Jun 30, 2019 15.25%
Mar 31, 2019 6.73%
Dec 31, 2018 59.94%
Sep 30, 2018 15.94%
Jun 30, 2018 172.25%
Mar 31, 2018 294.00%
Dec 31, 2017 189.95%
Sep 30, 2017 44.95%
Jun 30, 2017 -9.31%
Mar 31, 2017 -31.41%
Dec 31, 2016 53.68%
Sep 30, 2016 -46.76%
Jun 30, 2016 -43.57%
Mar 31, 2016 -33.46%
Dec 31, 2015 104.52%
Sep 30, 2015 -33.41%
Jun 30, 2015 -68.19%
Mar 31, 2015 -71.42%
Dec 31, 2014 -75.68%
Sep 30, 2014 -69.78%
Jun 30, 2014 -36.32%
Mar 31, 2014 -31.29%
Dec 31, 2013 -74.26%
Sep 30, 2013 -30.74%
Jun 30, 2013 -34.23%